Cargando…
Molecular Background, Clinical Features and Management of Pediatric Mastocytosis: Status 2021
Pediatric mastocytosis is a heterogeneous disease characterized by accumulation of mast cells in the skin and less frequently in other organs. Somatic or germline mutations in the KIT proto-oncogene are detected in most patients. Cutaneous mastocytosis is the most common form of the disease in child...
Autores principales: | Lange, Magdalena, Hartmann, Karin, Carter, Melody C., Siebenhaar, Frank, Alvarez-Twose, Ivan, Torrado, Inés, Brockow, Knut, Renke, Joanna, Irga-Jaworska, Ninela, Plata-Nazar, Katarzyna, Ługowska-Umer, Hanna, Czarny, Justyna, Belloni Fortina, Anna, Caroppo, Francesca, Nowicki, Roman J., Nedoszytko, Bogusław, Niedoszytko, Marek, Valent, Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7961542/ https://www.ncbi.nlm.nih.gov/pubmed/33806685 http://dx.doi.org/10.3390/ijms22052586 |
Ejemplares similares
-
Mediator-Related Symptoms and Anaphylaxis in Children with Mastocytosis
por: Brockow, Knut, et al.
Publicado: (2021) -
New Approach to Paediatric Mastocytosis: Implications of KIT D816V Mutation Detection in Peripheral Blood
por: CZARNY, Justyna, et al.
Publicado: (2020) -
-2518A/G polymorphism of monocyte chemotactic protein 1 (MCP-1/CCL2) is associated with cutaneous mastocytosis
por: Ługowska-Umer, Hanna, et al.
Publicado: (2022) -
Mastocytosis, MCAS, and Related Disorders—Diagnosis, Classification, and Therapy
por: Niedoszytko, Marek, et al.
Publicado: (2021) -
Cutaneous mastocytosis treatment: strategies, limitations and perspectives
por: Czarny, Justyna, et al.
Publicado: (2018)